These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7583074)

  • 1. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
    QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
    Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
    Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
    Askari FK; Greenson J; Dick RD; Johnson VD; Brewer GJ
    J Lab Clin Med; 2003 Dec; 142(6):385-90. PubMed ID: 14713890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.
    Arnon R; Calderon JF; Schilsky M; Emre S; Shneider BL
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):596-602. PubMed ID: 17460493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience.
    Sini M; Sorbello O; Sanna F; Battolu F; Civolani A; Fanni D; Faa G; Demelia L
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):111-7. PubMed ID: 23011036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
    Scheinberg IH; Jaffe ME; Sternlieb I
    N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological abnormalities in Wilson's disease are reversible.
    Lingam S; Wilson J; Nazer H; Mowat AP
    Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.
    Walshe JM
    Q J Med; 1989 Mar; 70(263):253-63. PubMed ID: 2602537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 16. Wilson's disease with depression and parkinsonism.
    Chan KH; Cheung RT; Au-Yeung KM; Mak W; Cheng TS; Ho SL
    J Clin Neurosci; 2005 Apr; 12(3):303-5. PubMed ID: 15851088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
    Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B; Chung SJ; Shin HW
    J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.